The current results indicated that the iNTR is a novel, independent prognostic factor for a high rate of disease recurrence and poor OS in patients with resectable NSCLC.
Laboratory of Clinical and Experimental Pathology, Louis Pasteur Hospital, University Hospital Center of Nice, Nice, France.
Cancer. 2012 Mar;118(6):1726-37
© Galenicom 1999-2013